02 May 2003
A proteomic analysis of poly(ADP-ribose)-binding proteins and PARP interactorsV. Bouchard, J. Hunter, J. Gagne, B. Chabot, B. Labrecque, M. Rouleau, A. Droit, M. Bonicalzi, G. Poirier
Med Sci Monit 2003; 9(1): 4-0 :: ID: 14989
Recent findings have highlighted the fact that the regulation of poly(ADP-ribose) (pADPr) metabolism is not only important for DNA repair but is also involved in apoptosis signaling and for the regulation of circadian rhythms [1, 2]. To gain insight into the cellular pathways in which PARPs and pADPr are involved, we have initiated a study to identify pADPr-binding proteins as well as protein interactors of three nuclear PARPs, PARP-1, PARP-2 and PARP-3, using a proteomic approach. To identify pADPr-binding proteins, Rotofor fractions of a HeLa cellular extract were screened with 32P-labeled pADPr using a protein blot assay. The most abundant pADPr-binding proteins were identified by peptide mass finger printing as hnRNPs, a family of proteins that bind pre-mRNA into functional complexes involved in mRNA maturation and transport to the cytoplasm. PARP interactors were isolated by immunoprecipitations. Endogenous PARP-1 was immunoprecipitated from HeLa S3 nuclei using the PARP-1 specific antibodies C2-10, F1-23 and 96-72. PARP-2 and PARP-3, transiently expressed in COS-7 cells as N-terminal fusions with the FLAG epitope, were immunoprecipitated with the M2 anti-FLAG antibody. Immunoprecipitated proteins digested with trypsin were identified by mass spectrometry and Western analysis. This approach identified previously reported PARP-1 interactors such as topoisomerase I, histones H1, H3 and H4, hnRNPs and nucleolin, thus confirming the interactions between these proteins and PARP-1 and validating our methodology. New interactions were also found, in particular with nucleolar proteins such as EBNA1-binding protein. The analysis of PARP-2 and PARP-3 interactors is ongoing and results of this analysis will be presented.References: 1.Yu SW, Wang H, Poitras MF, Coombs C et al: Mediation of Poly(ADP-Ribose) Polymerase-1 Dependent Cell Death by Apoptosis Inducing Factor. Science, 2002; 297: 259-263 2.Panda S, Poirier GG, Kay SA: tej defines a role for poly(ADP-ribosyl)ation in establishing period length of the Arabidopsis circadian oscillator. Developmental Cell, 2002; 3(1): 51-61 3.Gagné JP, Hunter J, Labreque B et al: A proteomic approach to the identification of heterogeneous nuclear ribonucleoproteins as a new family of poly(ADP-ribose)-binding proteins. Biochemical J, 2003; In press
Keywords: proteomic, PARP interactors, poly(ADP-ribose) binding proteins, Mass Spectrometry
01 June 2023 : EditorialEditorial: Infectious Disease Surveillance Using Artificial Intelligence (AI) and its Role in Epidemic and Pandemic Preparedness
Med Sci Monit 2023; 29:e941209
08 Jun 2023 : Clinical ResearchRisk Factors for New Vertebral Compression Fracture After Percutaneous Vertebral Augmentation: A Retrospect...
Med Sci Monit In Press; DOI: 10.12659/MSM.940134
08 Jun 2023 : Clinical ResearchA Nomogram for Identifying HR+/Her2- Breast Cancer Patients with Positive Sentinel Lymph Nodes and Omitted ...
Med Sci Monit In Press; DOI: 10.12659/MSM.940124
08 Jun 2023 : Clinical ResearchBurden of COVID-19 on Mental Health of Resident Doctors in Poland
Med Sci Monit In Press; DOI: 10.12659/MSM.940208
08 Jun 2023 : Clinical ResearchRisk Prediction for Rapidly Progressive Interstitial Lung Disease in Anti-MDA5-Positive Dermatomyositis: Th...
Med Sci Monit In Press; DOI: 10.12659/MSM.940251
Most Viewed Current Articles
13 Nov 2021 : Clinical ResearchAcceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...
Med Sci Monit 2021; 27:e932788
30 Dec 2021 : Clinical ResearchRetrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...
Med Sci Monit 2021; 27:e935379
08 Mar 2022 : Review articleA Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...
Med Sci Monit 2022; 28:e936292
01 Jan 2022 : EditorialEditorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...
Med Sci Monit 2022; 28:e935952